Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-17
pubmed:abstractText
Epidemiological studies indicate that smoking is a negative, and exposure to pesticides, a positive risk factor for Parkinson's disease (PD). The purpose of this study was to assess the interplay between these two factors in a rodent model of nigrostriatal damage. To approach this, mice were administered nicotine, the agent in smoke implicated in neuroprotection. They were then treated for 3 weeks with the pesticide, paraquat, while nicotine was continued. Paraquat treatment decreased (25%) nigral dopaminergic neurons, consistent with previous results. Chronic nicotine administration significantly protected against nigral cell damage, with only a 16% decline in mice treated with both nicotine and paraquat. Paraquat treatment also decreased (14%) the striatal dopamine transporter, an effect that was partially prevented by nicotine. These changes in the striatal dopamine transporter paralleled those in a select striatal alpha6beta2* nicotinic receptor (nAChR) subtype. In contrast, striatal alpha4beta2* nAChRs were not decreased with paraquat treatment, suggesting they are on a differential subset of dopaminergic terminals. The results show that nicotine treatment partially protects against paraquat-induced declines in nigrostriatal dopaminergic neurons to which a select population of alpha6beta2* nAChRs are localized. Moreover, these data support epidemiological findings that environmental influences can elicit opposing effects on nigrostriatal dopaminergic integrity.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
180-90
pubmed:dateRevised
2011-9-22
pubmed:meshHeading
pubmed-meshheading:17227438-Analysis of Variance, pubmed-meshheading:17227438-Animals, pubmed-meshheading:17227438-Autoradiography, pubmed-meshheading:17227438-Bicyclo Compounds, Heterocyclic, pubmed-meshheading:17227438-Brain Injuries, pubmed-meshheading:17227438-Cell Count, pubmed-meshheading:17227438-Conotoxins, pubmed-meshheading:17227438-Corpus Striatum, pubmed-meshheading:17227438-Disease Models, Animal, pubmed-meshheading:17227438-Dopamine, pubmed-meshheading:17227438-Drug Interactions, pubmed-meshheading:17227438-Immunohistochemistry, pubmed-meshheading:17227438-Male, pubmed-meshheading:17227438-Mice, pubmed-meshheading:17227438-Mice, Inbred C57BL, pubmed-meshheading:17227438-Neurons, pubmed-meshheading:17227438-Nicotine, pubmed-meshheading:17227438-Nicotinic Agonists, pubmed-meshheading:17227438-Nicotinic Antagonists, pubmed-meshheading:17227438-Paraquat, pubmed-meshheading:17227438-Protein Binding, pubmed-meshheading:17227438-Pyridines, pubmed-meshheading:17227438-Receptors, Nicotinic, pubmed-meshheading:17227438-Substantia Nigra
pubmed:year
2007
pubmed:articleTitle
Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.
pubmed:affiliation
The Parkinson's Institute, Sunnyvale, CA 94089, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural